Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Milestone Pharmaceuticals reports Q2 EPS (39c), consensus (36c) » 16:20
08/10/22
08/10
16:20
08/10/22
16:20
MIST

Milestone Pharmaceuticals

$6.45 /

-0.2 (-3.01%)

Reports no revenue in Q2…

Reports no revenue in Q2 vs. $15K a year ago. As of June 30, Milestone had cash, cash equivalents, and short-term investments of $86.2M and 29.9 million common shares and 12.3 million common shares issuable upon exercise of pre-funded warrants outstanding. "Progress continues across our Phase 3 PSVT clinical program. Notably with the recent crossing of the 180th event in the RAPID trial, we now focus on the final stages of data cleaning and analysis and look forward to reporting top line data in the middle of the second half of this year," said CEO Joseph Oliveto.

ShowHide Related Items >><<
MIST Milestone Pharmaceuticals
$6.45 /

-0.2 (-3.01%)

MIST Milestone Pharmaceuticals
$6.45 /

-0.2 (-3.01%)

05/02/22 Piper Sandler
Milestone data support confidence in Phase III study, says Piper Sandler
04/21/22 Piper Sandler
Piper upgrades Milestone Pharmaceuticals on etripamil confidence
04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
MIST Milestone Pharmaceuticals
$6.45 /

-0.2 (-3.01%)

MIST Milestone Pharmaceuticals
$6.45 /

-0.2 (-3.01%)

Over a month ago
Conference/Events
Milestone Pharmaceuticals management to meet virtually with Oppenheimer » 04:55
07/13/22
07/13
04:55
07/13/22
04:55
MIST

Milestone Pharmaceuticals

$6.09 /

-0.08 (-1.30%)

Virtual Meeting to be…

Virtual Meeting to be held on July 13 hosted by Oppenheimer.

ShowHide Related Items >><<
MIST Milestone Pharmaceuticals
$6.09 /

-0.08 (-1.30%)

MIST Milestone Pharmaceuticals
$6.09 /

-0.08 (-1.30%)

05/02/22 Piper Sandler
Milestone data support confidence in Phase III study, says Piper Sandler
04/21/22 Piper Sandler
Piper upgrades Milestone Pharmaceuticals on etripamil confidence
04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
MIST Milestone Pharmaceuticals
$6.09 /

-0.08 (-1.30%)

MIST Milestone Pharmaceuticals
$6.09 /

-0.08 (-1.30%)

Conference/Events
Milestone Pharmaceuticals management to meet virtually with Oppenheimer » 07:39
07/11/22
07/11
07:39
07/11/22
07:39
MIST

Milestone Pharmaceuticals

$6.20 /

+0.01 (+0.16%)

Virtual Meeting to be…

Virtual Meeting to be held on July 13 hosted by Oppenheimer.

ShowHide Related Items >><<
MIST Milestone Pharmaceuticals
$6.20 /

+0.01 (+0.16%)

MIST Milestone Pharmaceuticals
$6.20 /

+0.01 (+0.16%)

05/02/22 Piper Sandler
Milestone data support confidence in Phase III study, says Piper Sandler
04/21/22 Piper Sandler
Piper upgrades Milestone Pharmaceuticals on etripamil confidence
04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
MIST Milestone Pharmaceuticals
$6.20 /

+0.01 (+0.16%)

MIST Milestone Pharmaceuticals
$6.20 /

+0.01 (+0.16%)

Over a quarter ago
Earnings
Milestone Pharmaceuticals reports Q1 EPS (33c), consensus (39c) » 07:17
05/12/22
05/12
07:17
05/12/22
07:17
MIST

Milestone Pharmaceuticals

$5.46 /

-0.13 (-2.33%)

As of March 31, Milestone…

As of March 31, Milestone had cash, cash equivalents, and short-term investments of $100.2M and 29.9 million common shares and 12.3 million common shares issuable upon exercise of pre-funded warrants outstanding. "The beginning of 2022 has been a productive time for Milestone, marked by continued progress advancing our lead Phase 3 program, etripamil, for patients with PSVT," said CEO Joseph Oliveto. "Of note, we were particularly excited by the recent presentation of NODE-302 at the Heart Rhythm Society's Heart Rhythm 2022 conference which highlighted data that continued to support the potential of etripamil as a self-treatment option for patients with PSVT, including those patients experiencing multiple episodes. We remain optimistic for the eventual safety profile of etripamil as clinical trial experience with the repeat dose regimen grows, and we look forward to reporting topline results from our Phase 3 RAPID trial in the middle of the second half of 2022."

ShowHide Related Items >><<
MIST Milestone Pharmaceuticals
$5.46 /

-0.13 (-2.33%)

MIST Milestone Pharmaceuticals
$5.46 /

-0.13 (-2.33%)

05/02/22 Piper Sandler
Milestone data support confidence in Phase III study, says Piper Sandler
04/21/22 Piper Sandler
Piper upgrades Milestone Pharmaceuticals on etripamil confidence
04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
MIST Milestone Pharmaceuticals
$5.46 /

-0.13 (-2.33%)

MIST Milestone Pharmaceuticals
$5.46 /

-0.13 (-2.33%)

Recommendations
Milestone data support confidence in Phase III study, says Piper Sandler » 14:16
05/02/22
05/02
14:16
05/02/22
14:16
MIST

Milestone Pharmaceuticals

$6.38 /

-0.28 (-4.20%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff reiterates an Overweight rating on Milestone Pharmaceuticals with a $10 price target after the company over the weekend presented Phase III NODE-302 open label extension data on etripamil. In NODE-302, 60.2% of 188 adjudicated paroxysmal supraventricular tachycardia events treated with etripamil resolved within a median of 15.5 minutes, Tenthoff tells investors in a research note. The analyst says these data support his confidence that etripamil can meet the primary endpoint in the ongoing Phase III RAPID trial of time to conversion to normal sinus rhythm within 30 minutes when reported in September or October.

ShowHide Related Items >><<
MIST Milestone Pharmaceuticals
$6.38 /

-0.28 (-4.20%)

MIST Milestone Pharmaceuticals
$6.38 /

-0.28 (-4.20%)

04/21/22 Piper Sandler
Piper upgrades Milestone Pharmaceuticals on etripamil confidence
04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
MIST Milestone Pharmaceuticals
$6.38 /

-0.28 (-4.20%)

MIST Milestone Pharmaceuticals
$6.38 /

-0.28 (-4.20%)

Hot Stocks
Milestone Pharmaceuticals announces data from Phase 3 NODE-302 study » 17:52
05/01/22
05/01
17:52
05/01/22
17:52
MIST

Milestone Pharmaceuticals

$6.68 /

+0.075 (+1.14%)

Milestone Pharmaceuticals…

Milestone Pharmaceuticals announced data from NODE-302, its Phase 3 open-label extension study of etripamil nasal spray, the company's novel, investigational, calcium channel blocker in patients with paroxysmal supraventricular tachycardia. NODE-302 was a single-arm, open-label extension study of the Phase 3, randomized, double-blind, placebo-controlled NODE-301 study. The primary objective of the NODE-302 study was to assess the safety of patients dosing 70 mg of etripamil over multiple episodes. Patients were eligible to participate in NODE-302 if they dosed themselves for a perceived episode of PSVT in NODE-301. In NODE-302, patients self-administered 70 mg of etripamil nasal spray in response to a perceived PSVT episode after a failed attempt at a vagal maneuver and were monitored for five hours using an ambulatory cardiac monitoring system. The study allowed patients to treat up to 11 unique episodes. Of 198 eligible NODE-301 patients, 169 enrolled in NODE-302 and 105 experienced a perceived episode of PSVT, self-administered etripamil, and were included in the safety population. The calculated median number of treated episodes extrapolated over the course of one year was 3.7. Of the 105 patients who treated themselves for a perceived episode, 92 (88%) had a positively adjudicated PSVT episode. There was a total of 188 positively adjudicated PSVT episodes over a median of 7.4 months follow-up. Overall, the PSVT conversion rate at 30 minutes following etripamil administration was 60.2%, with a median time to conversion of 15.5 minutes. Among 40 patients who self-treated two consecutive episodes, 21 of 26 who converted on their first episode were also successfully converted on their second. Moreover, the need for ED intervention to terminate a PSVT episode was low. Etripamil was generally well-tolerated, with adverse events consistent with those observed in previous trials; the majority of adverse events related to treatment were localized to the nasopharynx administration site, and were mild and brief.

ShowHide Related Items >><<
MIST Milestone Pharmaceuticals
$6.68 /

+0.075 (+1.14%)

MIST Milestone Pharmaceuticals
$6.68 /

+0.075 (+1.14%)

04/21/22 Piper Sandler
Piper upgrades Milestone Pharmaceuticals on etripamil confidence
04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
MIST Milestone Pharmaceuticals
$6.68 /

+0.075 (+1.14%)

MIST Milestone Pharmaceuticals
$6.68 /

+0.075 (+1.14%)

On The Fly
What You Missed On Wall Street On Friday » 16:06
04/22/22
04/22
16:06
04/22/22
16:06
UAL

United Airlines

$51.46 /

+0.63 (+1.24%)

, SPIR

Spire Global

$1.75 /

-0.01 (-0.57%)

, UBSFY

Ubisoft

$8.62 /

+1.26 (+17.12%)

, SNAP

Snap

$29.41 /

-0.02 (-0.07%)

, VZ

Verizon

$52.13 /

-3.015 (-5.47%)

, AXP

American Express

$181.21 /

-4.65 (-2.50%)

, GPS

Gap

$11.65 /

-2.635 (-18.45%)

, BUD

AB InBev

$59.35 /

-2.095 (-3.41%)

, AAL

American Airlines

$20.22 /

-0.025 (-0.12%)

, JBLU

JetBlue

$12.88 /

-0.655 (-4.84%)

, MIST

Milestone Pharmaceuticals

$7.23 /

-0.06 (-0.82%)

, BA

Boeing

$177.24 /

-3.805 (-2.10%)

, RKLY

Rockley Photonics

$3.22 /

-0.02 (-0.62%)

, BX

Blackstone

$110.80 /

-1.86 (-1.65%)

, KKR

KKR

$52.00 /

-1.87 (-3.47%)

, CD

Chindata

$4.84 /

+0.455 (+10.38%)

, ATEN

A10 Networks

$14.39 /

+1.17 (+8.85%)

, DNA

Ginkgo Bioworks

$3.41 /

-0.04 (-1.16%)

, MPW

Medical Properties Trust

$18.80 /

-1.525 (-7.50%)

, NEM

Newmont

$74.50 /

-2.56 (-3.32%)

, HCA

HCA Healthcare

$209.62 /

-59.7 (-22.17%)

, SAM

Boston Beer

$349.00 /

+0.62 (+0.18%)

, ISRG

Intuitive Surgical

$253.44 /

-41.255 (-14.00%)

, CLF

Cleveland-Cliffs

$28.86 /

-0.69 (-2.34%)

, KMB

Kimberly-Clark

$138.86 /

+10.86 (+8.48%)

, SLB

Schlumberger

$41.81 /

+1.23 (+3.03%)

, BBBY

Bed Bath & Beyond

$18.23 /

+1.885 (+11.54%)

Get caught up quickly on…

ShowHide Related Items >><<
VZ Verizon
$52.13 /

-3.015 (-5.47%)

UBSFY Ubisoft
$8.62 /

+1.26 (+17.12%)

UAL United Airlines
$51.46 /

+0.63 (+1.24%)

SPIR Spire Global
$1.75 /

-0.01 (-0.57%)

SNAP Snap
$29.41 /

-0.02 (-0.07%)

SLB Schlumberger
$41.81 /

+1.23 (+3.03%)

SAM Boston Beer
$349.00 /

+0.62 (+0.18%)

RKLY Rockley Photonics
$3.22 /

-0.02 (-0.62%)

NEM Newmont
$74.50 /

-2.56 (-3.32%)

MPW Medical Properties Trust
$18.80 /

-1.525 (-7.50%)

MIST Milestone Pharmaceuticals
$7.23 /

-0.06 (-0.82%)

KMB Kimberly-Clark
$138.86 /

+10.86 (+8.48%)

KKR KKR
$52.00 /

-1.87 (-3.47%)

JBLU JetBlue
$12.88 /

-0.655 (-4.84%)

ISRG Intuitive Surgical
$253.44 /

-41.255 (-14.00%)

HCA HCA Healthcare
$209.62 /

-59.7 (-22.17%)

GPS Gap
$11.65 /

-2.635 (-18.45%)

DNA Ginkgo Bioworks
$3.41 /

-0.04 (-1.16%)

CLF Cleveland-Cliffs
$28.86 /

-0.69 (-2.34%)

CD Chindata
$4.84 /

+0.455 (+10.38%)

BX Blackstone
$110.80 /

-1.86 (-1.65%)

BUD AB InBev
$59.35 /

-2.095 (-3.41%)

BBBY Bed Bath & Beyond
$18.23 /

+1.885 (+11.54%)

BA Boeing
$177.24 /

-3.805 (-2.10%)

AXP American Express
$181.21 /

-4.65 (-2.50%)

ATEN A10 Networks
$14.39 /

+1.17 (+8.85%)

AAL American Airlines
$20.22 /

-0.025 (-0.12%)

UAL United Airlines
$51.46 /

+0.63 (+1.24%)

04/22/22 MKM Partners
United Airlines price target raised to $59 from $53 at MKM Partners
04/22/22 Morgan Stanley
United Airlines price target raised to $67 from $62 at Morgan Stanley
04/22/22 Argus
United Airlines upgraded to Buy from Hold at Argus
04/22/22 Cowen
United Airlines price target raised to $86.50 from $78 at Cowen
SPIR Spire Global
$1.75 /

-0.01 (-0.57%)

04/21/22 Raymond James
Spire Global initiated with an Outperform at Raymond James
03/28/22 CJS Securities
Spire Global initiated with an Outperform at CJS Securities
03/03/22 Stifel
Spire Global initiated with a Buy at Stifel
01/19/22 BofA
Spire Global downgraded to Underperform at BofA on valuation
UBSFY Ubisoft
$8.62 /

+1.26 (+17.12%)

04/19/22 Goldman Sachs
Ubisoft assumed with Sell from Neutral at Goldman Sachs
03/28/22 Jefferies
Frontier Developments upgraded to Buy from Hold at Jefferies
02/22/22 Benchmark
Ubisoft upgraded to Hold from Sell at Benchmark
02/18/22 Barclays
Ubisoft price target lowered to EUR 47 from EUR 53.20 at Barclays
SNAP Snap
$29.41 /

-0.02 (-0.07%)

04/22/22 RBC Capital
Snap price target lowered to $35 from $42 at RBC Capital
04/22/22 MKM Partners
Snap price target lowered to $41 from $47 at MKM Partners
04/22/22 Jefferies
Snap fundamentals intact despite mixed Q1, says Jefferies
04/22/22 Evercore ISI
Snap price target lowered to $47 from $58 at Evercore ISI
VZ Verizon
$52.13 /

-3.015 (-5.47%)

04/19/22 Northland
Casa Systems upgraded to Outperform from Market Perform at Northland
04/11/22 JPMorgan
AT&T upgraded to Overweight from Neutral at JPMorgan
02/01/22 Citi
Citi constructive on wireless landscape with T-Mobile top pick
01/26/22 Deutsche Bank
Verizon price target raised to $59 from $57 at Deutsche Bank
AXP American Express
$181.21 /

-4.65 (-2.50%)

04/11/22 JPMorgan
American Express downgraded to Neutral from Overweight at JPMorgan
03/28/22 Morgan Stanley
American Express price target raised to $223 from $218 at Morgan Stanley
03/17/22 BofA
American Express price target raised to $206 from $204 at BofA
03/17/22 Morgan Stanley
American Express positioned for multiple expansion, says Morgan Stanley
GPS Gap
$11.65 /

-2.635 (-18.45%)

04/22/22 Craig-Hallum
Land's End downgraded to Hold from Buy at Craig-Hallum
04/22/22 B. Riley
Gap price target lowered to $13 from $15 at B. Riley
04/22/22 BMO Capital
Gap price target lowered to $13 from $16 at BMO Capital
04/22/22 Baird
Gap price target lowered to $14 from $18 at Baird
BUD AB InBev
$59.35 /

-2.095 (-3.41%)

04/20/22 Barclays
AB InBev price target lowered to EUR 72 from EUR 83 at Barclays
04/12/22 Deutsche Bank
AB InBev price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/04/22 RBC Capital
AB InBev price target raised to EUR 65 from EUR 60 at RBC Capital
04/04/22 RBC Capital
AB InBev price target raised to EUR 65 from EUR 60 at RBC Capital
AAL American Airlines
$20.22 /

-0.025 (-0.12%)

04/22/22 Argus
American Airlines upgraded to Buy from Hold at Argus
04/22/22 JPMorgan
American Airlines upgraded to Neutral with $26 target at JPMorgan
04/22/22 Deutsche Bank
American Airlines price target raised to $25 from $23 at Deutsche Bank
04/22/22 Barclays
American Airlines price target raised to $20 from $15 at Barclays
JBLU JetBlue
$12.88 /

-0.655 (-4.84%)

04/22/22 Deutsche Bank
JetBlue downgraded to Hold on headwinds at Deutsche Bank
04/22/22 Deutsche Bank
JetBlue downgraded to Hold from Buy at Deutsche Bank
04/12/22 Wolfe Research
JetBlue downgraded to Underperform from Peer Perform at Wolfe Research
04/11/22 MKM Partners
JetBlue upgraded to Neutral at MKM Partners on valuation
MIST Milestone Pharmaceuticals
$7.23 /

-0.06 (-0.82%)

04/21/22 Piper Sandler
Piper upgrades Milestone Pharmaceuticals on etripamil confidence
04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
BA Boeing
$177.24 /

-3.805 (-2.10%)

04/22/22 Benchmark
Boeing price target lowered to $250 from $270 at Benchmark
04/21/22 JPMorgan
Boeing progress with 787 good news, says JPMorgan
04/08/22 Morgan Stanley
Boeing price target lowered to $230 from $288 at Morgan Stanley
03/30/22 Jefferies
China Southern's 3-year outlook from Boeing down 20 aircraft, says Jefferies
RKLY Rockley Photonics
$3.22 /

-0.02 (-0.62%)

03/09/22 Northland
Rockley Photonics price target lowered to $10 from $20 at Northland
03/09/22 Needham
Rockley Photonics price target lowered to $8 from $15 at Needham
12/22/21 BofA
Rockley Photonics downgraded to Neutral from Buy at BofA
12/22/21 BofA
Rockley Photonics downgraded to Neutral from Buy at BofA
BX Blackstone
$110.80 /

-1.86 (-1.65%)

04/22/22 BMO Capital
Blackstone price target raised to $142 from $124 at BMO Capital
04/22/22 Deutsche Bank
Blackstone price target lowered to $182 from $186 at Deutsche Bank
04/12/22 Citi
Blackstone price target lowered to $117 from $132.50 at Citi
04/07/22 Deutsche Bank
Blackstone price target raised to $186 from $180 at Deutsche Bank
KKR KKR
$52.00 /

-1.87 (-3.47%)

04/19/22 Wells Fargo
KKR price target lowered to $73 from $83 at Wells Fargo
04/13/22 Oppenheimer
KKR price target raised to $81 from $76 at Oppenheimer
04/13/22 Oppenheimer
Oppenheimer upgrades Apollo Global following 23% year-to-date pullback
CD Chindata
$4.84 /

+0.455 (+10.38%)

04/22/22 Jefferies
Selloff in China IDC stocks 'significantly overdone,' says Jefferies
03/07/22 Credit Suisse
Chindata upgraded to Outperform from Neutral at Credit Suisse
08/18/21
Fly Intel: Top five analyst initiations
08/18/21 JPMorgan
Chindata initiated with an Overweight at JPMorgan
ATEN A10 Networks
$14.39 /

+1.17 (+8.85%)

10/29/21 BWS Financial
A10 Networks price target raised to $20 from $17 at BWS Financial
07/28/21 BWS Financial
A10 Networks price target raised to $17 from $13.50 at BWS Financial
06/23/21 Craig-Hallum
A10 Networks initiated with a Buy at Craig-Hallum
06/23/21 Craig-Hallum
A10 Networks initiated with a Buy at Craig-Hallum
DNA Ginkgo Bioworks
$3.41 /

-0.04 (-1.16%)

03/31/22 BTIG
Ginkgo Bioworks price target lowered to $6 from $12 at BTIG
03/29/22 Cowen
Ginkgo Bioworks weakness a buying opportunity, says Cowen
03/02/22 Cowen
Ginkgo Bioworks initiated with an Outperform at Cowen
02/23/22 Goldman Sachs
Ginkgo Bioworks initiated with a Neutral at Goldman Sachs
MPW Medical Properties Trust
$18.80 /

-1.525 (-7.50%)

04/22/22 Jefferies
Medical Properties Trust downgraded to Hold at Jefferies on slowing growth
04/22/22 Jefferies
Medical Properties Trust downgraded to Hold from Buy at Jefferies
03/11/22 BofA
Medical Properties Trust downgraded to Neutral from Buy at BofA
02/01/22 Credit Suisse
Medical Properties Trust initiated with an Outperform at Credit Suisse
NEM Newmont
$74.50 /

-2.56 (-3.32%)

04/20/22 National Bank
Newmont downgraded to Sector Perform on valuation at National Bank
04/19/22 Credit Suisse
Newmont downgraded to Neutral from Outperform at Credit Suisse
03/09/22 Jefferies
Newmont price target raised to $72 from $67 at Jefferies
02/28/22 BofA
Newmont price target raised to $75 from $70 at BofA
HCA HCA Healthcare
$209.62 /

-59.7 (-22.17%)

03/28/22 Wells Fargo
HCA Healthcare initiated with an Equal Weight at Wells Fargo
02/07/22 BofA
BOFA adds Zoetis and Microsoft to best ideas list, removes two
01/31/22 BMO Capital
HCA Healthcare price target lowered to $250 from $275 at BMO Capital
01/31/22 Citi
HCA Healthcare price target lowered to $277 from $306 at Citi
SAM Boston Beer
$349.00 /

+0.62 (+0.18%)

04/22/22 Evercore ISI
Boston Beer price target lowered to $400 from $600 at Evercore ISI
04/22/22 Credit Suisse
Boston Beer price target lowered to $620 from $670 at Credit Suisse
04/22/22 Cowen
Boston Beer price target lowered to $375 from $500 at Cowen
04/22/22 Deutsche Bank
Boston Beer price target lowered to $337 from $420 at Deutsche Bank
ISRG Intuitive Surgical
$253.44 /

-41.255 (-14.00%)

04/22/22 Evercore ISI
Intuitive Surgical price target lowered to $280 from $294 at Evercore ISI
04/22/22 Raymond James
Intuitive Surgical price target lowered to $330 from $334 at Raymond James
04/22/22 Bernstein
Bernstein calls Intuitive Surgical 'top pick,' would buy on weakness
04/22/22 Piper Sandler
Intuitive Surgical price target raised to $316 from $310 at Piper Sandler
CLF Cleveland-Cliffs
$28.86 /

-0.69 (-2.34%)

04/19/22 Credit Suisse
Cleveland-Cliffs price target raised to $37 from $34 at Credit Suisse
03/28/22 B. Riley
Cleveland-Cliffs price target raised to $46 from $37 at B. Riley
03/24/22 JPMorgan
Cleveland-Cliffs price target raised to $44 from $37 at JPMorgan
03/15/22 Citi
Cleveland-Cliffs price target raised to $28 from $25 at Citi
KMB Kimberly-Clark
$138.86 /

+10.86 (+8.48%)

04/01/22 Barclays
Kimberly-Clark price target lowered to $121 from $127 at Barclays
03/30/22 JPMorgan
Kimberly-Clark price target lowered to $113 from $118 at JPMorgan
03/29/22 Goldman Sachs
Kimberly-Clark price target lowered to $124 from $130 at Goldman Sachs
03/15/22 Wells Fargo
Kimberly-Clark price target lowered to $128 from $140 at Wells Fargo
SLB Schlumberger
$41.81 /

+1.23 (+3.03%)

04/11/22 Piper Sandler
ChampionX upgraded to Overweight amid higher OFS estimates at Piper Sandler
04/11/22 Piper Sandler
Schlumberger upgraded to Overweight amid higher OFS estimates at Piper Sandler
04/11/22 Piper Sandler
Schlumberger upgraded to Overweight from Neutral at Piper Sandler
04/08/22 Stifel
Schlumberger price target raised to $50 from $44 at Stifel
BBBY Bed Bath & Beyond
$18.23 /

+1.885 (+11.54%)

04/14/22 Telsey Advisory
Bed Bath & Beyond downgraded to Underperform at Telsey Advisory
04/14/22 B. Riley
Bed Bath & Beyond shares still offer value, says B. Riley
04/13/22 Wells Fargo
Wells Fargo halves Bed Bath & Beyond target, says take profits today
04/13/22 Wells Fargo
Bed Bath & Beyond price target lowered to $10 from $20 at Wells Fargo
VZ Verizon
$52.13 /

-3.015 (-5.47%)

UBSFY Ubisoft
$8.62 /

+1.26 (+17.12%)

UAL United Airlines
$51.46 /

+0.63 (+1.24%)

SPIR Spire Global
$1.75 /

-0.01 (-0.57%)

SNAP Snap
$29.41 /

-0.02 (-0.07%)

SLB Schlumberger
$41.81 /

+1.23 (+3.03%)

SAM Boston Beer
$349.00 /

+0.62 (+0.18%)

RKLY Rockley Photonics
$3.22 /

-0.02 (-0.62%)

NEM Newmont
$74.50 /

-2.56 (-3.32%)

MPW Medical Properties Trust
$18.80 /

-1.525 (-7.50%)

MIST Milestone Pharmaceuticals
$7.23 /

-0.06 (-0.82%)

KMB Kimberly-Clark
$138.86 /

+10.86 (+8.48%)

KKR KKR
$52.00 /

-1.87 (-3.47%)

JBLU JetBlue
$12.88 /

-0.655 (-4.84%)

ISRG Intuitive Surgical
$253.44 /

-41.255 (-14.00%)

HCA HCA Healthcare
$209.62 /

-59.7 (-22.17%)

GPS Gap
$11.65 /

-2.635 (-18.45%)

DNA Ginkgo Bioworks
$3.41 /

-0.04 (-1.16%)

CLF Cleveland-Cliffs
$28.86 /

-0.69 (-2.34%)

CD Chindata
$4.84 /

+0.455 (+10.38%)

BX Blackstone
$110.80 /

-1.86 (-1.65%)

BUD AB InBev
$59.35 /

-2.095 (-3.41%)

BBBY Bed Bath & Beyond
$18.23 /

+1.885 (+11.54%)

BA Boeing
$177.24 /

-3.805 (-2.10%)

AXP American Express
$181.21 /

-4.65 (-2.50%)

ATEN A10 Networks
$14.39 /

+1.17 (+8.85%)

AAL American Airlines
$20.22 /

-0.025 (-0.12%)

  • 08
    Dec
  • 08
    Dec
VZ Verizon
$52.13 /

-3.015 (-5.47%)

UBSFY Ubisoft
$8.62 /

+1.26 (+17.12%)

UAL United Airlines
$51.46 /

+0.63 (+1.24%)

SNAP Snap
$29.41 /

-0.02 (-0.07%)

SLB Schlumberger
$41.81 /

+1.23 (+3.03%)

SAM Boston Beer
$349.00 /

+0.62 (+0.18%)

RKLY Rockley Photonics
$3.22 /

-0.02 (-0.62%)

KKR KKR
$52.00 /

-1.87 (-3.47%)

JBLU JetBlue
$12.88 /

-0.655 (-4.84%)

ISRG Intuitive Surgical
$253.44 /

-41.255 (-14.00%)

GPS Gap
$11.65 /

-2.635 (-18.45%)

CD Chindata
$4.84 /

+0.455 (+10.38%)

BX Blackstone
$110.80 /

-1.86 (-1.65%)

BBBY Bed Bath & Beyond
$18.23 /

+1.885 (+11.54%)

BA Boeing
$177.24 /

-3.805 (-2.10%)

AXP American Express
$181.21 /

-4.65 (-2.50%)

AAL American Airlines
$20.22 /

-0.025 (-0.12%)

VZ Verizon
$52.13 /

-3.015 (-5.47%)

UBSFY Ubisoft
$8.62 /

+1.26 (+17.12%)

UAL United Airlines
$51.46 /

+0.63 (+1.24%)

SPIR Spire Global
$1.75 /

-0.01 (-0.57%)

SNAP Snap
$29.41 /

-0.02 (-0.07%)

SLB Schlumberger
$41.81 /

+1.23 (+3.03%)

SAM Boston Beer
$349.00 /

+0.62 (+0.18%)

RKLY Rockley Photonics
$3.22 /

-0.02 (-0.62%)

KMB Kimberly-Clark
$138.86 /

+10.86 (+8.48%)

KKR KKR
$52.00 /

-1.87 (-3.47%)

JBLU JetBlue
$12.88 /

-0.655 (-4.84%)

ISRG Intuitive Surgical
$253.44 /

-41.255 (-14.00%)

HCA HCA Healthcare
$209.62 /

-59.7 (-22.17%)

DNA Ginkgo Bioworks
$3.41 /

-0.04 (-1.16%)

CLF Cleveland-Cliffs
$28.86 /

-0.69 (-2.34%)

BX Blackstone
$110.80 /

-1.86 (-1.65%)

BUD AB InBev
$59.35 /

-2.095 (-3.41%)

BBBY Bed Bath & Beyond
$18.23 /

+1.885 (+11.54%)

BA Boeing
$177.24 /

-3.805 (-2.10%)

AXP American Express
$181.21 /

-4.65 (-2.50%)

ATEN A10 Networks
$14.39 /

+1.17 (+8.85%)

VZ Verizon
$52.13 /

-3.015 (-5.47%)

UAL United Airlines
$51.46 /

+0.63 (+1.24%)

SPIR Spire Global
$1.75 /

-0.01 (-0.57%)

SNAP Snap
$29.41 /

-0.02 (-0.07%)

SLB Schlumberger
$41.81 /

+1.23 (+3.03%)

RKLY Rockley Photonics
$3.22 /

-0.02 (-0.62%)

NEM Newmont
$74.50 /

-2.56 (-3.32%)

MPW Medical Properties Trust
$18.80 /

-1.525 (-7.50%)

KMB Kimberly-Clark
$138.86 /

+10.86 (+8.48%)

KKR KKR
$52.00 /

-1.87 (-3.47%)

JBLU JetBlue
$12.88 /

-0.655 (-4.84%)

ISRG Intuitive Surgical
$253.44 /

-41.255 (-14.00%)

GPS Gap
$11.65 /

-2.635 (-18.45%)

DNA Ginkgo Bioworks
$3.41 /

-0.04 (-1.16%)

CLF Cleveland-Cliffs
$28.86 /

-0.69 (-2.34%)

BX Blackstone
$110.80 /

-1.86 (-1.65%)

BBBY Bed Bath & Beyond
$18.23 /

+1.885 (+11.54%)

BA Boeing
$177.24 /

-3.805 (-2.10%)

AXP American Express
$181.21 /

-4.65 (-2.50%)

AAL American Airlines
$20.22 /

-0.025 (-0.12%)

On The Fly
What You Missed On Wall Street This Morning » 12:09
04/22/22
04/22
12:09
04/22/22
12:09
SNAP

Snap

$29.54 /

+0.11 (+0.37%)

, VZ

Verizon

$51.66 /

-3.48 (-6.31%)

, AXP

American Express

$183.41 /

-2.45 (-1.32%)

, GPS

Gap

$11.73 /

-2.555 (-17.89%)

, BUD

AB InBev

$59.88 /

-1.565 (-2.55%)

, RKLY

Rockley Photonics

$2.91 /

-0.33 (-10.20%)

, RNLSY

Renault

$4.94 /

+0.03 (+0.61%)

, CD

Chindata

$4.88 /

+0.495 (+11.29%)

, AMZN

Amazon.com

$2,924.35 /

-43.11 (-1.45%)

, RACE

Ferrari

$212.96 /

-4.08 (-1.88%)

, SAM

Boston Beer

$351.38 /

+3 (+0.86%)

, ISRG

Intuitive Surgical

$258.22 /

-36.475 (-12.38%)

, CLF

Cleveland-Cliffs

$29.39 /

-0.16 (-0.54%)

, KMB

Kimberly-Clark

$140.11 /

+12.11 (+9.46%)

, HCA

HCA Healthcare

$219.82 /

-49.5 (-18.38%)

, SLB

Schlumberger

$41.50 /

+0.925 (+2.28%)

, ATEN

A10 Networks

$14.66 /

+1.44 (+10.89%)

, DNA

Ginkgo Bioworks

$3.52 /

+0.07 (+2.03%)

, MPW

Medical Properties Trust

$19.05 /

-1.275 (-6.27%)

, NEM

Newmont

$73.36 /

-3.7 (-4.80%)

, UAL

United Airlines

$52.27 /

+1.44 (+2.83%)

, AAL

American Airlines

$20.23 /

-0.01 (-0.05%)

, JBLU

JetBlue

$13.04 /

-0.49 (-3.62%)

, MIST

Milestone Pharmaceuticals

$7.36 /

+0.07 (+0.96%)

, SPIR

Spire Global

$1.76 /

+ (+0.00%)

Get caught up quickly on…

ShowHide Related Items >><<
VZ Verizon
$51.66 /

-3.48 (-6.31%)

UAL United Airlines
$52.27 /

+1.44 (+2.83%)

SPIR Spire Global
$1.76 /

+ (+0.00%)

SNAP Snap
$29.54 /

+0.11 (+0.37%)

SLB Schlumberger
$41.50 /

+0.925 (+2.28%)

SAM Boston Beer
$351.38 /

+3 (+0.86%)

RNLSY Renault
$4.94 /

+0.03 (+0.61%)

RKLY Rockley Photonics
$2.91 /

-0.33 (-10.20%)

RACE Ferrari
$212.96 /

-4.08 (-1.88%)

NEM Newmont
$73.36 /

-3.7 (-4.80%)

MPW Medical Properties Trust
$19.05 /

-1.275 (-6.27%)

MIST Milestone Pharmaceuticals
$7.36 /

+0.07 (+0.96%)

KMB Kimberly-Clark
$140.11 /

+12.11 (+9.46%)

JBLU JetBlue
$13.04 /

-0.49 (-3.62%)

ISRG Intuitive Surgical
$258.22 /

-36.475 (-12.38%)

HCA HCA Healthcare
$219.82 /

-49.5 (-18.38%)

GPS Gap
$11.73 /

-2.555 (-17.89%)

DNA Ginkgo Bioworks
$3.52 /

+0.07 (+2.03%)

CLF Cleveland-Cliffs
$29.39 /

-0.16 (-0.54%)

CD Chindata
$4.88 /

+0.495 (+11.29%)

BUD AB InBev
$59.88 /

-1.565 (-2.55%)

AXP American Express
$183.41 /

-2.45 (-1.32%)

ATEN A10 Networks
$14.66 /

+1.44 (+10.89%)

AMZN Amazon.com
$2,924.35 /

-43.11 (-1.45%)

AAL American Airlines
$20.23 /

-0.01 (-0.05%)

SNAP Snap
$29.54 /

+0.11 (+0.37%)

04/22/22 RBC Capital
Snap price target lowered to $35 from $42 at RBC Capital
04/22/22 MKM Partners
Snap price target lowered to $41 from $47 at MKM Partners
04/22/22 Jefferies
Snap fundamentals intact despite mixed Q1, says Jefferies
04/22/22 Evercore ISI
Snap price target lowered to $47 from $58 at Evercore ISI
VZ Verizon
$51.66 /

-3.48 (-6.31%)

04/19/22 Northland
Casa Systems upgraded to Outperform from Market Perform at Northland
04/11/22 JPMorgan
AT&T upgraded to Overweight from Neutral at JPMorgan
02/01/22 Citi
Citi constructive on wireless landscape with T-Mobile top pick
01/26/22 Deutsche Bank
Verizon price target raised to $59 from $57 at Deutsche Bank
AXP American Express
$183.41 /

-2.45 (-1.32%)

04/11/22 JPMorgan
American Express downgraded to Neutral from Overweight at JPMorgan
03/28/22 Morgan Stanley
American Express price target raised to $223 from $218 at Morgan Stanley
03/17/22 BofA
American Express price target raised to $206 from $204 at BofA
03/17/22 Morgan Stanley
American Express positioned for multiple expansion, says Morgan Stanley
GPS Gap
$11.73 /

-2.555 (-17.89%)

04/22/22 Craig-Hallum
Land's End downgraded to Hold from Buy at Craig-Hallum
04/22/22 B. Riley
Gap price target lowered to $13 from $15 at B. Riley
04/22/22 BMO Capital
Gap price target lowered to $13 from $16 at BMO Capital
04/22/22 Baird
Gap price target lowered to $14 from $18 at Baird
BUD AB InBev
$59.88 /

-1.565 (-2.55%)

04/20/22 Barclays
AB InBev price target lowered to EUR 72 from EUR 83 at Barclays
04/12/22 Deutsche Bank
AB InBev price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/04/22 RBC Capital
AB InBev price target raised to EUR 65 from EUR 60 at RBC Capital
04/04/22 RBC Capital
AB InBev price target raised to EUR 65 from EUR 60 at RBC Capital
RKLY Rockley Photonics
$2.91 /

-0.33 (-10.20%)

03/09/22 Northland
Rockley Photonics price target lowered to $10 from $20 at Northland
03/09/22 Needham
Rockley Photonics price target lowered to $8 from $15 at Needham
12/22/21 BofA
Rockley Photonics downgraded to Neutral from Buy at BofA
12/22/21 BofA
Rockley Photonics downgraded to Neutral from Buy at BofA
RNLSY Renault
$4.94 /

+0.03 (+0.61%)

04/19/22 UBS
Renault price target lowered to EUR 40 from EUR 49 at UBS
04/14/22 Barclays
Renault price target lowered to EUR 25 from EUR 33 at Barclays
04/06/22 JPMorgan
Renault price target lowered to EUR 55 from EUR 62 at JPMorgan
03/31/22 Deutsche Bank
Renault price target lowered to EUR 35 from EUR 40 at Deutsche Bank
CD Chindata
$4.88 /

+0.495 (+11.29%)

04/22/22 Jefferies
Selloff in China IDC stocks 'significantly overdone,' says Jefferies
03/07/22 Credit Suisse
Chindata upgraded to Outperform from Neutral at Credit Suisse
08/18/21
Fly Intel: Top five analyst initiations
08/18/21 JPMorgan
Chindata initiated with an Overweight at JPMorgan
AMZN Amazon.com
$2,924.35 /

-43.11 (-1.45%)

04/22/22 Credit Suisse
Amazon.com remains top pick at Credit Suisse ahead of Q1 report
04/21/22 Wedbush
Wedbush expects Amazon to benefit from robust consumer demand
04/20/22 UBS
Amazon.com price target lowered to $4,550 from $4,625 at UBS
04/20/22 MKM Partners
Amazon.com price target lowered to $4,000 from $4,100 at MKM Partners
RACE Ferrari
$212.96 /

-4.08 (-1.88%)

04/12/22 Exane BNP Paribas
Ferrari upgraded to Outperform from Neutral at Exane BNP Paribas
04/04/22 UBS
Ferrari price target raised to $263 from $260 at UBS
02/03/22 Morgan Stanley
Rivian preferred over Lucid by 87% of surveyed investors, says Morgan Stanley
02/03/22 UBS
Ferrari price target lowered to $277 from $305 at UBS
SAM Boston Beer
$351.38 /

+3 (+0.86%)

04/22/22 Evercore ISI
Boston Beer price target lowered to $400 from $600 at Evercore ISI
04/22/22 Credit Suisse
Boston Beer price target lowered to $620 from $670 at Credit Suisse
04/22/22 Cowen
Boston Beer price target lowered to $375 from $500 at Cowen
04/22/22 Deutsche Bank
Boston Beer price target lowered to $337 from $420 at Deutsche Bank
ISRG Intuitive Surgical
$258.22 /

-36.475 (-12.38%)

04/22/22 Evercore ISI
Intuitive Surgical price target lowered to $280 from $294 at Evercore ISI
04/22/22 Raymond James
Intuitive Surgical price target lowered to $330 from $334 at Raymond James
04/22/22 Bernstein
Bernstein calls Intuitive Surgical 'top pick,' would buy on weakness
04/22/22 Piper Sandler
Intuitive Surgical price target raised to $316 from $310 at Piper Sandler
CLF Cleveland-Cliffs
$29.39 /

-0.16 (-0.54%)

04/19/22 Credit Suisse
Cleveland-Cliffs price target raised to $37 from $34 at Credit Suisse
03/28/22 B. Riley
Cleveland-Cliffs price target raised to $46 from $37 at B. Riley
03/24/22 JPMorgan
Cleveland-Cliffs price target raised to $44 from $37 at JPMorgan
03/15/22 Citi
Cleveland-Cliffs price target raised to $28 from $25 at Citi
KMB Kimberly-Clark
$140.11 /

+12.11 (+9.46%)

04/01/22 Barclays
Kimberly-Clark price target lowered to $121 from $127 at Barclays
03/30/22 JPMorgan
Kimberly-Clark price target lowered to $113 from $118 at JPMorgan
03/29/22 Goldman Sachs
Kimberly-Clark price target lowered to $124 from $130 at Goldman Sachs
03/15/22 Wells Fargo
Kimberly-Clark price target lowered to $128 from $140 at Wells Fargo
HCA HCA Healthcare
$219.82 /

-49.5 (-18.38%)

03/28/22 Wells Fargo
HCA Healthcare initiated with an Equal Weight at Wells Fargo
02/07/22 BofA
BOFA adds Zoetis and Microsoft to best ideas list, removes two
01/31/22 BMO Capital
HCA Healthcare price target lowered to $250 from $275 at BMO Capital
01/31/22 Citi
HCA Healthcare price target lowered to $277 from $306 at Citi
SLB Schlumberger
$41.50 /

+0.925 (+2.28%)

04/11/22 Piper Sandler
ChampionX upgraded to Overweight amid higher OFS estimates at Piper Sandler
04/11/22 Piper Sandler
Schlumberger upgraded to Overweight amid higher OFS estimates at Piper Sandler
04/11/22 Piper Sandler
Schlumberger upgraded to Overweight from Neutral at Piper Sandler
04/08/22 Stifel
Schlumberger price target raised to $50 from $44 at Stifel
ATEN A10 Networks
$14.66 /

+1.44 (+10.89%)

10/29/21 BWS Financial
A10 Networks price target raised to $20 from $17 at BWS Financial
07/28/21 BWS Financial
A10 Networks price target raised to $17 from $13.50 at BWS Financial
06/23/21 Craig-Hallum
A10 Networks initiated with a Buy at Craig-Hallum
06/23/21 Craig-Hallum
A10 Networks initiated with a Buy at Craig-Hallum
DNA Ginkgo Bioworks
$3.52 /

+0.07 (+2.03%)

03/31/22 BTIG
Ginkgo Bioworks price target lowered to $6 from $12 at BTIG
03/29/22 Cowen
Ginkgo Bioworks weakness a buying opportunity, says Cowen
03/02/22 Cowen
Ginkgo Bioworks initiated with an Outperform at Cowen
02/23/22 Goldman Sachs
Ginkgo Bioworks initiated with a Neutral at Goldman Sachs
MPW Medical Properties Trust
$19.05 /

-1.275 (-6.27%)

04/22/22 Jefferies
Medical Properties Trust downgraded to Hold at Jefferies on slowing growth
04/22/22 Jefferies
Medical Properties Trust downgraded to Hold from Buy at Jefferies
03/11/22 BofA
Medical Properties Trust downgraded to Neutral from Buy at BofA
02/01/22 Credit Suisse
Medical Properties Trust initiated with an Outperform at Credit Suisse
NEM Newmont
$73.36 /

-3.7 (-4.80%)

04/20/22 National Bank
Newmont downgraded to Sector Perform on valuation at National Bank
04/19/22 Credit Suisse
Newmont downgraded to Neutral from Outperform at Credit Suisse
03/09/22 Jefferies
Newmont price target raised to $72 from $67 at Jefferies
02/28/22 BofA
Newmont price target raised to $75 from $70 at BofA
UAL United Airlines
$52.27 /

+1.44 (+2.83%)

04/22/22 MKM Partners
United Airlines price target raised to $59 from $53 at MKM Partners
04/22/22 Morgan Stanley
United Airlines price target raised to $67 from $62 at Morgan Stanley
04/22/22 Argus
United Airlines upgraded to Buy from Hold at Argus
04/22/22 Cowen
United Airlines price target raised to $86.50 from $78 at Cowen
AAL American Airlines
$20.23 /

-0.01 (-0.05%)

04/22/22 Argus
American Airlines upgraded to Buy from Hold at Argus
04/22/22 JPMorgan
American Airlines upgraded to Neutral with $26 target at JPMorgan
04/22/22 Deutsche Bank
American Airlines price target raised to $25 from $23 at Deutsche Bank
04/22/22 Barclays
American Airlines price target raised to $20 from $15 at Barclays
JBLU JetBlue
$13.04 /

-0.49 (-3.62%)

04/22/22 Deutsche Bank
JetBlue downgraded to Hold on headwinds at Deutsche Bank
04/22/22 Deutsche Bank
JetBlue downgraded to Hold from Buy at Deutsche Bank
04/12/22 Wolfe Research
JetBlue downgraded to Underperform from Peer Perform at Wolfe Research
04/11/22 MKM Partners
JetBlue upgraded to Neutral at MKM Partners on valuation
MIST Milestone Pharmaceuticals
$7.36 /

+0.07 (+0.96%)

04/21/22 Piper Sandler
Piper upgrades Milestone Pharmaceuticals on etripamil confidence
04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
SPIR Spire Global
$1.76 /

+ (+0.00%)

04/21/22 Raymond James
Spire Global initiated with an Outperform at Raymond James
03/28/22 CJS Securities
Spire Global initiated with an Outperform at CJS Securities
03/03/22 Stifel
Spire Global initiated with a Buy at Stifel
01/19/22 BofA
Spire Global downgraded to Underperform at BofA on valuation
VZ Verizon
$51.66 /

-3.48 (-6.31%)

UAL United Airlines
$52.27 /

+1.44 (+2.83%)

SPIR Spire Global
$1.76 /

+ (+0.00%)

SNAP Snap
$29.54 /

+0.11 (+0.37%)

SLB Schlumberger
$41.50 /

+0.925 (+2.28%)

SAM Boston Beer
$351.38 /

+3 (+0.86%)

RKLY Rockley Photonics
$2.91 /

-0.33 (-10.20%)

RACE Ferrari
$212.96 /

-4.08 (-1.88%)

NEM Newmont
$73.36 /

-3.7 (-4.80%)

MPW Medical Properties Trust
$19.05 /

-1.275 (-6.27%)

MIST Milestone Pharmaceuticals
$7.36 /

+0.07 (+0.96%)

KMB Kimberly-Clark
$140.11 /

+12.11 (+9.46%)

JBLU JetBlue
$13.04 /

-0.49 (-3.62%)

ISRG Intuitive Surgical
$258.22 /

-36.475 (-12.38%)

HCA HCA Healthcare
$219.82 /

-49.5 (-18.38%)

GPS Gap
$11.73 /

-2.555 (-17.89%)

DNA Ginkgo Bioworks
$3.52 /

+0.07 (+2.03%)

CLF Cleveland-Cliffs
$29.39 /

-0.16 (-0.54%)

CD Chindata
$4.88 /

+0.495 (+11.29%)

BUD AB InBev
$59.88 /

-1.565 (-2.55%)

AXP American Express
$183.41 /

-2.45 (-1.32%)

ATEN A10 Networks
$14.66 /

+1.44 (+10.89%)

AMZN Amazon.com
$2,924.35 /

-43.11 (-1.45%)

AAL American Airlines
$20.23 /

-0.01 (-0.05%)

  • 08
    Dec
VZ Verizon
$51.66 /

-3.48 (-6.31%)

UAL United Airlines
$52.27 /

+1.44 (+2.83%)

SNAP Snap
$29.54 /

+0.11 (+0.37%)

SLB Schlumberger
$41.50 /

+0.925 (+2.28%)

SAM Boston Beer
$351.38 /

+3 (+0.86%)

RNLSY Renault
$4.94 /

+0.03 (+0.61%)

RKLY Rockley Photonics
$2.91 /

-0.33 (-10.20%)

RACE Ferrari
$212.96 /

-4.08 (-1.88%)

JBLU JetBlue
$13.04 /

-0.49 (-3.62%)

ISRG Intuitive Surgical
$258.22 /

-36.475 (-12.38%)

GPS Gap
$11.73 /

-2.555 (-17.89%)

CD Chindata
$4.88 /

+0.495 (+11.29%)

AXP American Express
$183.41 /

-2.45 (-1.32%)

AMZN Amazon.com
$2,924.35 /

-43.11 (-1.45%)

AAL American Airlines
$20.23 /

-0.01 (-0.05%)

VZ Verizon
$51.66 /

-3.48 (-6.31%)

UAL United Airlines
$52.27 /

+1.44 (+2.83%)

SPIR Spire Global
$1.76 /

+ (+0.00%)

SNAP Snap
$29.54 /

+0.11 (+0.37%)

SLB Schlumberger
$41.50 /

+0.925 (+2.28%)

SAM Boston Beer
$351.38 /

+3 (+0.86%)

RKLY Rockley Photonics
$2.91 /

-0.33 (-10.20%)

RACE Ferrari
$212.96 /

-4.08 (-1.88%)

KMB Kimberly-Clark
$140.11 /

+12.11 (+9.46%)

JBLU JetBlue
$13.04 /

-0.49 (-3.62%)

ISRG Intuitive Surgical
$258.22 /

-36.475 (-12.38%)

HCA HCA Healthcare
$219.82 /

-49.5 (-18.38%)

GPS Gap
$11.73 /

-2.555 (-17.89%)

DNA Ginkgo Bioworks
$3.52 /

+0.07 (+2.03%)

CLF Cleveland-Cliffs
$29.39 /

-0.16 (-0.54%)

BUD AB InBev
$59.88 /

-1.565 (-2.55%)

AXP American Express
$183.41 /

-2.45 (-1.32%)

ATEN A10 Networks
$14.66 /

+1.44 (+10.89%)

AMZN Amazon.com
$2,924.35 /

-43.11 (-1.45%)

AAL American Airlines
$20.23 /

-0.01 (-0.05%)

VZ Verizon
$51.66 /

-3.48 (-6.31%)

UAL United Airlines
$52.27 /

+1.44 (+2.83%)

SPIR Spire Global
$1.76 /

+ (+0.00%)

SNAP Snap
$29.54 /

+0.11 (+0.37%)

SLB Schlumberger
$41.50 /

+0.925 (+2.28%)

RKLY Rockley Photonics
$2.91 /

-0.33 (-10.20%)

RACE Ferrari
$212.96 /

-4.08 (-1.88%)

NEM Newmont
$73.36 /

-3.7 (-4.80%)

MPW Medical Properties Trust
$19.05 /

-1.275 (-6.27%)

KMB Kimberly-Clark
$140.11 /

+12.11 (+9.46%)

JBLU JetBlue
$13.04 /

-0.49 (-3.62%)

ISRG Intuitive Surgical
$258.22 /

-36.475 (-12.38%)

GPS Gap
$11.73 /

-2.555 (-17.89%)

DNA Ginkgo Bioworks
$3.52 /

+0.07 (+2.03%)

CLF Cleveland-Cliffs
$29.39 /

-0.16 (-0.54%)

AXP American Express
$183.41 /

-2.45 (-1.32%)

AMZN Amazon.com
$2,924.35 /

-43.11 (-1.45%)

AAL American Airlines
$20.23 /

-0.01 (-0.05%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:44
04/22/22
04/22
10:44
04/22/22
10:44
UAL

United Airlines

$52.44 /

+1.61 (+3.17%)

, AAL

American Airlines

$20.55 /

+0.31 (+1.53%)

, MIST

Milestone Pharmaceuticals

$7.41 /

+0.12 (+1.65%)

, BXP

Boston Properties

$127.77 /

+0.62 (+0.49%)

, KRC

Kilroy Realty

$74.80 /

-0.14 (-0.19%)

, DOW

Dow Inc.

$70.89 /

+1.435 (+2.07%)

, JBLU

JetBlue

$13.19 /

-0.34 (-2.51%)

, AVAV

AeroVironment

$90.30 /

-1.63 (-1.77%)

, UNP

Union Pacific

$237.97 /

-6.39 (-2.61%)

, CNI

Canadian National

$125.67 /

-1.645 (-1.29%)

, LE

Land's End

$14.23 /

-1.7 (-10.67%)

, GPS

Gap

$11.77 /

-2.515 (-17.61%)

, SPIR

Spire Global

$1.76 /

+ (+0.00%)

, EA

Electronic Arts

$125.50 /

+1.79 (+1.45%)

, TTWO

Take-Two

$132.57 /

+1.04 (+0.79%)

, CGTX

Cognition Therapeutics

$3.24 /

+0.18 (+5.88%)

, SGHC

Super Group

$9.31 /

+0.14 (+1.53%)

Institutional investors…

ShowHide Related Items >><<
UNP Union Pacific
$237.97 /

-6.39 (-2.61%)

UAL United Airlines
$52.44 /

+1.61 (+3.17%)

TTWO Take-Two
$132.57 /

+1.04 (+0.79%)

SPIR Spire Global
$1.76 /

+ (+0.00%)

SGHC Super Group
$9.31 /

+0.14 (+1.53%)

MIST Milestone Pharmaceuticals
$7.41 /

+0.12 (+1.65%)

LE Land's End
$14.23 /

-1.7 (-10.67%)

KRC Kilroy Realty
$74.80 /

-0.14 (-0.19%)

JBLU JetBlue
$13.19 /

-0.34 (-2.51%)

GPS Gap
$11.77 /

-2.515 (-17.61%)

EA Electronic Arts
$125.50 /

+1.79 (+1.45%)

DOW Dow Inc.
$70.89 /

+1.435 (+2.07%)

CNI Canadian National
$125.67 /

-1.645 (-1.29%)

CGTX Cognition Therapeutics
$3.24 /

+0.18 (+5.88%)

BXP Boston Properties
$127.77 /

+0.62 (+0.49%)

AVAV AeroVironment
$90.30 /

-1.63 (-1.77%)

AAL American Airlines
$20.55 /

+0.31 (+1.53%)

UAL United Airlines
$52.44 /

+1.61 (+3.17%)

04/22/22 MKM Partners
United Airlines price target raised to $59 from $53 at MKM Partners
04/22/22 Morgan Stanley
United Airlines price target raised to $67 from $62 at Morgan Stanley
04/22/22 Argus
United Airlines upgraded to Buy from Hold at Argus
04/22/22 Cowen
United Airlines price target raised to $86.50 from $78 at Cowen
AAL American Airlines
$20.55 /

+0.31 (+1.53%)

04/22/22 Argus
American Airlines upgraded to Buy from Hold at Argus
04/22/22 JPMorgan
American Airlines upgraded to Neutral with $26 target at JPMorgan
04/22/22 Deutsche Bank
American Airlines price target raised to $25 from $23 at Deutsche Bank
04/22/22 Barclays
American Airlines price target raised to $20 from $15 at Barclays
MIST Milestone Pharmaceuticals
$7.41 /

+0.12 (+1.65%)

04/21/22 Piper Sandler
Piper upgrades Milestone Pharmaceuticals on etripamil confidence
04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
BXP Boston Properties
$127.77 /

+0.62 (+0.49%)

04/22/22 Mizuho
Mizuho upgrades Boston Properties, names top office REIT pick
04/21/22 Mizuho
Boston Properties upgraded to Buy from Neutral at Mizuho
04/14/22 Deutsche Bank
Boston Properties price target raised to $139 from $131 at Deutsche Bank
03/03/22 Evercore ISI
Evercore ISI shakes up Office REIT ratings with one upgrade, two downgrades
KRC Kilroy Realty
$74.80 /

-0.14 (-0.19%)

04/14/22 Deutsche Bank
Kilroy Realty price target raised to $75 from $74 at Deutsche Bank
03/03/22 Evercore ISI
Kilroy Realty downgraded to In Line from Outperform at Evercore ISI
DOW Dow Inc.
$70.89 /

+1.435 (+2.07%)

04/22/22 BMO Capital
Dow Inc. price target raised to $76 from $65 at BMO Capital
04/22/22 JPMorgan
Dow Inc. price target raised to $80 from $70 at JPMorgan
04/22/22 Deutsche Bank
Dow Inc. price target raised to $74 from $66 at Deutsche Bank
04/22/22 RBC Capital
Dow Inc. price target raised to $70 from $62 at RBC Capital
JBLU JetBlue
$13.19 /

-0.34 (-2.51%)

04/22/22 Deutsche Bank
JetBlue downgraded to Hold on headwinds at Deutsche Bank
04/22/22 Deutsche Bank
JetBlue downgraded to Hold from Buy at Deutsche Bank
04/12/22 Wolfe Research
JetBlue downgraded to Underperform from Peer Perform at Wolfe Research
04/11/22 MKM Partners
JetBlue upgraded to Neutral at MKM Partners on valuation
AVAV AeroVironment
$90.30 /

-1.63 (-1.77%)

04/22/22 Baird
Baird downgrades AeroVironment, sees Switchblade demand baked in after rally
04/22/22 Baird
AeroVironment downgraded to Neutral from Outperform at Baird
03/17/22 Baird
AeroVironment price target raised to $95 from $72 at Baird
03/04/22 Canaccord
AeroVironment upgraded at Canaccord on potential for exports amid war in Europe
UNP Union Pacific
$237.97 /

-6.39 (-2.61%)

04/22/22 Raymond James
Union Pacific price target raised to $285 from $280 at Raymond James
04/22/22 UBS
UBS cuts Union Pacific to Neutral on capacity constraints and service issues
04/22/22 UBS
Union Pacific downgraded to Neutral from Buy at UBS
04/22/22 Susquehanna
Union Pacific good for new money investors, says Susquehanna
CNI Canadian National
$125.67 /

-1.645 (-1.29%)

04/22/22 Raymond James
Canadian National downgraded to Market Perform from Outperform at Raymond James
04/14/22 CIBC
Canadian National price target raised to C$169 from C$165 at CIBC
04/08/22 National Bank
Canadian National price target lowered to C$168 from C$172 at National Bank
04/08/22 JPMorgan
Canadian National price target lowered to C$159 from C$171 at JPMorgan
LE Land's End
$14.23 /

-1.7 (-10.67%)

04/22/22 Craig-Hallum
Land's End downgraded to Hold from Buy at Craig-Hallum
03/17/22 Craig-Hallum
Land's End price target lowered to $35 from $45 at Craig-Hallum
07/21/21 Craig-Hallum
Land's End price target raised to $60 from $50 at Craig-Hallum
06/03/21 Craig-Hallum
Land's End price target raised to $50 from $45 at Craig-Hallum
GPS Gap
$11.77 /

-2.515 (-17.61%)

04/22/22 B. Riley
Gap price target lowered to $13 from $15 at B. Riley
04/22/22 BMO Capital
Gap price target lowered to $13 from $16 at BMO Capital
04/22/22 Baird
Gap price target lowered to $14 from $18 at Baird
SPIR Spire Global
$1.76 /

+ (+0.00%)

04/21/22 Raymond James
Spire Global initiated with an Outperform at Raymond James
03/28/22 CJS Securities
Spire Global initiated with an Outperform at CJS Securities
03/03/22 Stifel
Spire Global initiated with a Buy at Stifel
01/19/22 BofA
Spire Global downgraded to Underperform at BofA on valuation
EA Electronic Arts
$125.50 /

+1.79 (+1.45%)

04/22/22 Bernstein
Electronic Arts initiated with an Outperform at Bernstein
04/21/22 Stifel
Electronic Arts price target lowered to $155 from $165 at Stifel
04/19/22 Goldman Sachs
Electronic Arts assumed with Neutral from Buy at Goldman Sachs
02/02/22 Stifel
Electronic Arts price target lowered to $165 from $173 at Stifel
TTWO Take-Two
$132.57 /

+1.04 (+0.79%)

04/22/22 Bernstein
Take-Two initiated with an Outperform at Bernstein
04/19/22 Goldman Sachs
Take-Two assumed with Not Rated at Goldman Sachs
04/07/22 Benchmark
'Max Payne' remake not included in Take-Two FY23-FY25 guidance, says Benchmark
04/06/22 BofA
Take-Two reinstated with a Buy at BofA
CGTX Cognition Therapeutics
$3.24 /

+0.18 (+5.88%)

04/22/22 Ladenburg
Cognition Therapeutics initiated with a Buy at Ladenburg
01/24/22 B. Riley
Cognition Therapeutics price target lowered to $20 from $27 at B. Riley
11/03/21
Fly Intel: Top five analyst initiations
11/03/21 B. Riley
Cognition Therapeutics initiated with a Buy at B. Riley
SGHC Super Group
$9.31 /

+0.14 (+1.53%)

04/22/22 Canaccord
Canaccord starts 'consistently profitable' Super Group at Buy
04/22/22 Canaccord
Super Group initiated with a Buy at Canaccord
04/14/22 Benchmark
Super Group price target lowered to $14 from $16 at Benchmark
03/14/22 Needham
Super Group initiated with a Buy at Needham
UNP Union Pacific
$237.97 /

-6.39 (-2.61%)

UAL United Airlines
$52.44 /

+1.61 (+3.17%)

TTWO Take-Two
$132.57 /

+1.04 (+0.79%)

SPIR Spire Global
$1.76 /

+ (+0.00%)

MIST Milestone Pharmaceuticals
$7.41 /

+0.12 (+1.65%)

LE Land's End
$14.23 /

-1.7 (-10.67%)

KRC Kilroy Realty
$74.80 /

-0.14 (-0.19%)

JBLU JetBlue
$13.19 /

-0.34 (-2.51%)

GPS Gap
$11.77 /

-2.515 (-17.61%)

EA Electronic Arts
$125.50 /

+1.79 (+1.45%)

DOW Dow Inc.
$70.89 /

+1.435 (+2.07%)

CNI Canadian National
$125.67 /

-1.645 (-1.29%)

CGTX Cognition Therapeutics
$3.24 /

+0.18 (+5.88%)

BXP Boston Properties
$127.77 /

+0.62 (+0.49%)

AVAV AeroVironment
$90.30 /

-1.63 (-1.77%)

AAL American Airlines
$20.55 /

+0.31 (+1.53%)

  • 08
    Oct
UNP Union Pacific
$237.97 /

-6.39 (-2.61%)

UAL United Airlines
$52.44 /

+1.61 (+3.17%)

TTWO Take-Two
$132.57 /

+1.04 (+0.79%)

JBLU JetBlue
$13.19 /

-0.34 (-2.51%)

GPS Gap
$11.77 /

-2.515 (-17.61%)

EA Electronic Arts
$125.50 /

+1.79 (+1.45%)

AVAV AeroVironment
$90.30 /

-1.63 (-1.77%)

AAL American Airlines
$20.55 /

+0.31 (+1.53%)

UAL United Airlines
$52.44 /

+1.61 (+3.17%)

TTWO Take-Two
$132.57 /

+1.04 (+0.79%)

SPIR Spire Global
$1.76 /

+ (+0.00%)

SGHC Super Group
$9.31 /

+0.14 (+1.53%)

LE Land's End
$14.23 /

-1.7 (-10.67%)

JBLU JetBlue
$13.19 /

-0.34 (-2.51%)

GPS Gap
$11.77 /

-2.515 (-17.61%)

EA Electronic Arts
$125.50 /

+1.79 (+1.45%)

DOW Dow Inc.
$70.89 /

+1.435 (+2.07%)

CNI Canadian National
$125.67 /

-1.645 (-1.29%)

CGTX Cognition Therapeutics
$3.24 /

+0.18 (+5.88%)

AVAV AeroVironment
$90.30 /

-1.63 (-1.77%)

AAL American Airlines
$20.55 /

+0.31 (+1.53%)

UNP Union Pacific
$237.97 /

-6.39 (-2.61%)

UAL United Airlines
$52.44 /

+1.61 (+3.17%)

TTWO Take-Two
$132.57 /

+1.04 (+0.79%)

SPIR Spire Global
$1.76 /

+ (+0.00%)

SGHC Super Group
$9.31 /

+0.14 (+1.53%)

JBLU JetBlue
$13.19 /

-0.34 (-2.51%)

GPS Gap
$11.77 /

-2.515 (-17.61%)

EA Electronic Arts
$125.50 /

+1.79 (+1.45%)

DOW Dow Inc.
$70.89 /

+1.435 (+2.07%)

CNI Canadian National
$125.67 /

-1.645 (-1.29%)

BXP Boston Properties
$127.77 /

+0.62 (+0.49%)

AVAV AeroVironment
$90.30 /

-1.63 (-1.77%)

AAL American Airlines
$20.55 /

+0.31 (+1.53%)

Upgrade
Piper upgrades Milestone Pharmaceuticals on etripamil confidence » 16:19
04/21/22
04/21
16:19
04/21/22
16:19
MIST

Milestone Pharmaceuticals

$7.29 /

-0.05 (-0.68%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff upgraded Milestone Pharmaceuticals to Overweight from Neutral with a price target of $10, up from $8, after hosting a call with Dr. Bruce Stambler of the Piedmont Heart Institute on etripamil to treat paroxysmal supra-ventricular tachycardia. The analyst is now confident etripamil can meet the primary endpoint of time to conversion to normal sinus rhythm within 30 minutes. Additionally, patients can administer a second dose of etripamil if PSVT symptoms persist for over 10 minutes, further increasing the likelihood of conversion, Tenthoff tells investors in a research note. He adds that Milestone ended 2021 with cash of $114M, which should fund operations into the second half of 2023.

ShowHide Related Items >><<
MIST Milestone Pharmaceuticals
$7.29 /

-0.05 (-0.68%)

MIST Milestone Pharmaceuticals
$7.29 /

-0.05 (-0.68%)

04/21/22 Piper Sandler
Milestone Pharmaceuticals upgraded to Overweight from Neutral at Piper Sandler
MIST Milestone Pharmaceuticals
$7.29 /

-0.05 (-0.68%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.